The Antibiotic Resistance Market is expected to register a CAGR of 6.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Antibiotic Resistance Market report covers segmental analysis by Drug Class (Oxazolidinones, Cephalosporins, Tetracyclines, Lipoglycopeptides, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Antibiotic Resistance Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antibiotic Resistance Market Segmentation
Drug Class- Oxazolidinones
- Cephalosporins
- Tetracyclines
- Lipoglycopeptides
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
Strategic Insights
Antibiotic Resistance Market Growth Drivers- Increase in Surgical Procedures and Hospital-Acquired Infections (HAIs): As medical procedures become more advanced and frequent, the risk of hospital-acquired infections (HAIs) has also increased. The misuse of antibiotics in healthcare settings and the spread of multidrug-resistant organisms (MDROs) within hospitals are key contributors to the rise in antibiotic resistance. This has made it imperative for hospitals to adopt better infection control practices and for the Antibiotic Resistance Market to address the demand for targeted therapies and advanced diagnostic tools for resistant infections.
- Shift Towards Personalized Medicine and Targeted Therapies: Personalized medicine, which tailors treatment based on an individual’s genetic profile and the specific characteristics of pathogens, is gaining traction. By focusing on more precise and targeted antibiotics or alternative treatments, the market can reduce the overuse of broad-spectrum antibiotics and slow the progression of antibiotic resistance. This shift towards personalized and precision therapies is a significant growth driver for the Antibiotic Resistance Market.
- Proliferation of Antimicrobial Stewardship Programs: Antimicrobial stewardship programs (ASPs), which aim to optimize the use of antibiotics in healthcare settings, are playing an important role in controlling the rise of antibiotic resistance. These programs are increasingly being adopted by hospitals and healthcare institutions worldwide to ensure the responsible use of antibiotics. This growing focus on stewardship is contributing to the demand for novel antibiotics, diagnostics, and surveillance systems, driving the growth of the Antibiotic Resistance Market.
- Rise of Antimicrobial Stewardship Programs in Developing Regions: While antimicrobial stewardship programs (ASPs) have been common in developed countries, their implementation in developing regions will become a significant trend. In many low- and middle-income countries, antibiotic resistance is escalating due to the overuse and misuse of antibiotics. The Antibiotic Resistance Market will see a rise in initiatives aimed at strengthening ASPs in these regions, supported by international partnerships and local government policies. These programs will focus on promoting the responsible use of antibiotics and educating healthcare professionals, ultimately reducing the spread of resistance.
- Antibiotic Resistance in Agriculture and the Rise of Alternatives: The use of antibiotics in agriculture, particularly in livestock farming, is a critical contributor to antibiotic resistance. In the future, the market will see a shift towards alternative methods, such as the use of probiotics, enzymes, and phage therapy to reduce the reliance on antibiotics in farming. Additionally, governments and global organizations will impose stricter regulations on antibiotic use in agriculture, which will encourage the adoption of these alternative strategies, thereby influencing the demand for alternatives to traditional antibiotics.
- Growth of Biopharmaceutical Startups Focused on Antibiotic Resistance: With the increasing urgency around antibiotic resistance, there will be a surge in the establishment of biopharmaceutical startups dedicated to addressing this issue. These startups will drive innovation in the Antibiotic Resistance Market, focusing on new drug classes, repurposing existing drugs, or developing innovative technologies like CRISPR-based treatments. Venture capital investment in antibiotic resistance solutions will increase as both public and private sectors recognize the potential for groundbreaking solutions in combating this growing global threat.
- Development of Next-Generation Antibiotics: The growing prevalence of antibiotic resistance is creating a clear need for the development of next-generation antibiotics that can effectively target resistant pathogens. Pharmaceutical companies have an opportunity to invest in the discovery of new drug classes or the repurposing of existing molecules. This presents a chance to not only address the urgent need for novel antibiotics but also to gain a competitive edge in a rapidly expanding market, with the potential for significant returns on investment as new treatments come to market.
- Breakthrough Research in Alternative Therapies: With antibiotic resistance becoming increasingly difficult to manage, alternative therapies such as phage therapy, antimicrobial peptides, and immune-modulating treatments are emerging as viable solutions. Companies focused on researching and developing these alternatives have an opportunity to position themselves as leaders in the fight against antibiotic resistance. These alternative solutions could reshape the landscape of antimicrobial treatment, offering substantial market potential as resistance continues to grow globally.
- Focus on Infection Prevention and Control (IPC) Solutions: Prevention is key to slowing the spread of antibiotic resistance, and infection prevention and control (IPC) is a growing area of opportunity. Businesses that develop and market antiseptics, disinfectants, surface cleaning technologies, and personal protective equipment (PPE) have the chance to capitalize on the growing demand for effective infection control. Healthcare providers and institutions will increasingly invest in these products as part of their broader strategies to reduce hospital-acquired infections (HAIs) and antibiotic-resistant infections, making this an essential area for innovation and growth.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antibiotic Resistance Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antibiotic Resistance Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Antibiotic Resistance Market is expected to register a CAGR of 6.5% from 2025-2031.
The major factors impacting the Antibiotic Resistance Market are: Increase in Surgical Procedures and Hospital-Acquired Infections (HAIs), Shift Towards Personalized Medicine and Targeted Therapies and Proliferation of Antimicrobial Stewardship Programs
Key future trends in this market are - Rise of Antimicrobial Stewardship Programs in Developing Regions, Antibiotic Resistance in Agriculture and the Rise of Alternatives and Growth of Biopharmaceutical Startups Focused on Antibiotic Resistance
Key companies of this market are: Achaogen, Inc., Basilea Pharmaceutica Ltd., Entasis Therapeutics, Melinta Therapeutics, PARATEK therapeutics, Seres Therapeutics, Inc., Tetraphase Pharmaceuticals, Inc., Theravance Biopharma, Inc, Wockhardt therapeutics
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibiotic Resistance Market - By Drug Class
1.3.2 Antibiotic Resistance Market - By Distribution Channel
1.3.3 Antibiotic Resistance Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIBIOTIC RESISTANCE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIBIOTIC RESISTANCE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIBIOTIC RESISTANCE MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBIOTIC RESISTANCE - GLOBAL MARKET OVERVIEW
6.2. ANTIBIOTIC RESISTANCE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIBIOTIC RESISTANCE MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. OXAZOLIDINONES
7.3.1. Overview
7.3.2. Oxazolidinones Market Forecast and Analysis
7.4. CEPHALOSPORINS
7.4.1. Overview
7.4.2. Cephalosporins Market Forecast and Analysis
7.5. TETRACYCLINES
7.5.1. Overview
7.5.2. Tetracyclines Market Forecast and Analysis
7.6. LIPOGLYCOPEPTIDES
7.6.1. Overview
7.6.2. Lipoglycopeptides Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. ANTIBIOTIC RESISTANCE MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. DRUG STORES
8.5.1. Overview
8.5.2. Drug Stores Market Forecast and Analysis
8.6. ONLINE PHARMACIES
8.6.1. Overview
8.6.2. Online Pharmacies Market Forecast and Analysis
9. ANTIBIOTIC RESISTANCE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antibiotic Resistance Market Overview
9.1.2 North America Antibiotic Resistance Market Forecasts and Analysis
9.1.3 North America Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.1.4 North America Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antibiotic Resistance Market
9.1.5.1.1 United States Antibiotic Resistance Market by Drug Class
9.1.5.1.2 United States Antibiotic Resistance Market by Distribution Channel
9.1.5.2 Canada Antibiotic Resistance Market
9.1.5.2.1 Canada Antibiotic Resistance Market by Drug Class
9.1.5.2.2 Canada Antibiotic Resistance Market by Distribution Channel
9.1.5.3 Mexico Antibiotic Resistance Market
9.1.5.3.1 Mexico Antibiotic Resistance Market by Drug Class
9.1.5.3.2 Mexico Antibiotic Resistance Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Antibiotic Resistance Market Overview
9.2.2 Europe Antibiotic Resistance Market Forecasts and Analysis
9.2.3 Europe Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antibiotic Resistance Market
9.2.5.1.1 Germany Antibiotic Resistance Market by Drug Class
9.2.5.1.2 Germany Antibiotic Resistance Market by Distribution Channel
9.2.5.2 France Antibiotic Resistance Market
9.2.5.2.1 France Antibiotic Resistance Market by Drug Class
9.2.5.2.2 France Antibiotic Resistance Market by Distribution Channel
9.2.5.3 Italy Antibiotic Resistance Market
9.2.5.3.1 Italy Antibiotic Resistance Market by Drug Class
9.2.5.3.2 Italy Antibiotic Resistance Market by Distribution Channel
9.2.5.4 Spain Antibiotic Resistance Market
9.2.5.4.1 Spain Antibiotic Resistance Market by Drug Class
9.2.5.4.2 Spain Antibiotic Resistance Market by Distribution Channel
9.2.5.5 United Kingdom Antibiotic Resistance Market
9.2.5.5.1 United Kingdom Antibiotic Resistance Market by Drug Class
9.2.5.5.2 United Kingdom Antibiotic Resistance Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antibiotic Resistance Market Overview
9.3.2 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis
9.3.3 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antibiotic Resistance Market
9.3.5.1.1 Australia Antibiotic Resistance Market by Drug Class
9.3.5.1.2 Australia Antibiotic Resistance Market by Distribution Channel
9.3.5.2 China Antibiotic Resistance Market
9.3.5.2.1 China Antibiotic Resistance Market by Drug Class
9.3.5.2.2 China Antibiotic Resistance Market by Distribution Channel
9.3.5.3 India Antibiotic Resistance Market
9.3.5.3.1 India Antibiotic Resistance Market by Drug Class
9.3.5.3.2 India Antibiotic Resistance Market by Distribution Channel
9.3.5.4 Japan Antibiotic Resistance Market
9.3.5.4.1 Japan Antibiotic Resistance Market by Drug Class
9.3.5.4.2 Japan Antibiotic Resistance Market by Distribution Channel
9.3.5.5 South Korea Antibiotic Resistance Market
9.3.5.5.1 South Korea Antibiotic Resistance Market by Drug Class
9.3.5.5.2 South Korea Antibiotic Resistance Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antibiotic Resistance Market Overview
9.4.2 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis
9.4.3 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antibiotic Resistance Market
9.4.5.1.1 South Africa Antibiotic Resistance Market by Drug Class
9.4.5.1.2 South Africa Antibiotic Resistance Market by Distribution Channel
9.4.5.2 Saudi Arabia Antibiotic Resistance Market
9.4.5.2.1 Saudi Arabia Antibiotic Resistance Market by Drug Class
9.4.5.2.2 Saudi Arabia Antibiotic Resistance Market by Distribution Channel
9.4.5.3 U.A.E Antibiotic Resistance Market
9.4.5.3.1 U.A.E Antibiotic Resistance Market by Drug Class
9.4.5.3.2 U.A.E Antibiotic Resistance Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antibiotic Resistance Market Overview
9.5.2 South and Central America Antibiotic Resistance Market Forecasts and Analysis
9.5.3 South and Central America Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antibiotic Resistance Market
9.5.5.1.1 Brazil Antibiotic Resistance Market by Drug Class
9.5.5.1.2 Brazil Antibiotic Resistance Market by Distribution Channel
9.5.5.2 Argentina Antibiotic Resistance Market
9.5.5.2.1 Argentina Antibiotic Resistance Market by Drug Class
9.5.5.2.2 Argentina Antibiotic Resistance Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIBIOTIC RESISTANCE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIBIOTIC RESISTANCE MARKET, KEY COMPANY PROFILES
12.1. ACHAOGEN, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BASILEA PHARMACEUTICA LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ENTASIS THERAPEUTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MELINTA THERAPEUTICS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PARATEK THERAPEUTICS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SERES THERAPEUTICS, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TETRAPHASE PHARMACEUTICALS, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. THERAVANCE BIOPHARMA, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. WOCKHARDT THERAPEUTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Achaogen, Inc.
2. Basilea Pharmaceutica Ltd.
3. Entasis Therapeutics
4. Melinta Therapeutics
5. PARATEK therapeutics
6. Seres Therapeutics, Inc.
7. Tetraphase Pharmaceuticals, Inc.
8. Theravance Biopharma, Inc
9. Wockhardt therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For